Brief Report: Severe Pneumonitis After Combined Thoracic Radiotherapy and Osimertinib

Brief Report: Severe Pneumonitis After Combined Thoracic Radiotherapy and Osimertinib

Introduction: Osimertinib is an effective treatment for metastatic NSCLC. Occasionally, thoracic radiation therapy (TRT) is delivered to patients receiving osimertinib to treat residual or progressing pulmonary tumors. Anecdotal reports suggest that the delivery of TRT in combination with osimertini...

Full description

Bibliographic Details
Main Authors: Clayton P. Smith, MD, Michael Xiang, MD, PhD, Stephanie M. Yoon, MD, Alan Lee, MD, Dan Ruan, PhD, Jonathan W. Goldman, MD, Amy L. Cummings, MD, Aaron Lisberg, MD, Edward B. Garon, MD, MS, Drew Moghanaki, MD, MPH
Format: Article
Language:English
Published: Elsevier 2023-03-01
Series:JTO Clinical and Research Reports
Subjects:
Pneumonitis
Radiation therapy
Osimertinib
EGFR-mutated NSCLC
Online Access:http://www.sciencedirect.com/science/article/pii/S2666364323000073

Internet

http://www.sciencedirect.com/science/article/pii/S2666364323000073

Similar Items